Agenda of the 29th ISBP, Sept 9-11, Beijing, 2011

 

Pre-meeting course (Sponsored by Baxter)

 

Time of the course: September 9th, 2011

 

Meeting venue: Room 125, Teaching and Research Building, Peking University Third Hospital, Beijing. Pre-registration (free) is required and those who are interested to participate in the pre-meeting course are kindly asked to submit their application to isbp2011@yahoo.com.cn.

 

 

Program:

08:30-12:00 Session I: Developing high quality peritoneal dialysis program

08:30-09:00 Key elements of a successful PD program (Tao Wang, Beijing)

09:00-09:25 How to manage PD program (Hiroshi Kimura, Japan)

09:25-09:50 Current situation of PD after the Great East Japan Earthquake (Yoshinori Tsuchiya, Japan)

09:50-10:15 PD program development (Luo Xue Chun, Singapore)

 

10:15-10:30 Coffee break

 

10:30-11:00 Thailand experience (Piyatida Chuengsaman)

11:00-11:30 Taiwan experience (Jinbor Chen, Kaohsiung)

11:30-12:00 Mainland China experience (Qiang Yao, Shanghai)

 

12:15-13:00 Lunch

 

13:00-14:30 Session II: Developing high quality research projects in CKD and dialysis patients

13:00-13:15 Update on the research activities in Karolinska Institute (Bengt Lindholm, Sweden)

13:15-13:30 Nagoya Immune System in ESRD study (Sawako Kato, Japan)

13:30-13:45 Albumin as predictor of nutritional status and mortality (Tony Qureshi, Sweden)

13:45-14:00 Cardiovascular function in CKD (Shirley Hayashi, Brazil)

14:00-14:15 Nutritional assessment (Maria Chan, Australia)

 

14:15-14:30 Coffee break

 

14:30-17:30 Session III: Understanding and applying kinetic knowledge in clinical practice

14:30-15:00 Peritoneal solute and fluid transport: Introduction (Bengt Lindholm, Sweden)

15:00-15:30 Studies in peritoneal transport in China: Overview (Qiang Yao, Shanghai)

15:30-16:00 What would we like to know about fluid transport? (Jacek Waniewski, Sweden)

16:00-16:30 How to apply kinetic knowledge in clinical practice? (Tao Wang, Beijing)

16:30-17:30 Kinetic studies in PD and HD patients (Xing-wei Zhe and Hong-lei Yu, China)

 

29th ISBP Annual Meeting

Time of the meeting: September 10-11, 2011

 

Meeting venue: Beijing International Convention Center

The registration desk will be open on September 9 (14:00pm-21:00pm), Sept 10 (8:00am -5:30pm) and September 11 (8:00am-11:30am)

 

Agenda:

 

September 10

 

08:00-08:40 Opening ceremony (Chaired by Tadao Akizawa, Japan and Fa-lei Zheng, Beijing. Hall 2)

1. 08:00-08:10 Welcome speech by the president of ISBP (Tadao Akizawa, Japan)

2. 08:10-08:20 Welcome speech by the Chinese government officer

3. 08:20-08:30 Welcome speech by the local organizer (Shu-zhong Bai, China)

4. 08:30-08:40 Welcome speech by the president of the meeting (Tao Wang, China)

 

08:40-9:30 ISBP Award session (Chaired by Tadao Akizawa, Japan and Ingrid Ledebo, Sweden. Hall 2)

1. 08:40-08:50 Introducing the ISBP award and the awardee (Ingrid Ledebo, Sweden)

2. 08:50-09:30Award lecture: Dialysis development and CKD prevention in Taiwan: lesson that we learn (Chiu-Ching Huang, Taichung)

 

9:30-10:15 Keynote lecture (Chaired by Andrew Davenport, UK and Li Zuo, Beijing. Hall 2)

GI related uremic toxins: implication for dialysis therapy (Toshimitsu Niwa, Japan)

 

10:15-10:25 Best abstract award session (Chaired by Andrew Davenport, UK and Li Zuo, Beijing. Hall 2)

The six best abstract awards will be given to those awardees by Dr. Andre A. Kaplan, USA.

 

10:25-10:45 Break, poster and exhibition

 

10:45-12:00 Debate (Chaired by Andre A. Kaplan, USA and Tao Wang, Beijing. Hall 2)

10:45-11:10 Center based hemodialysis has to be the main treatment modality for ESRD patients (Xin-ling Liang, Guangzhou)

11:10-11:35 Home based hemodialysis should be the major dialysis modality (John Agar, Australia)

11:35-12:00 Peritoneal dialysis should be the main dialysis modality (Wai-kei Lo, Hong Kong)

 

12:00-13:30 Lunch symposium

Lunch symposium1: Round table discussion on the new hemodialysis care delivery: chain organization of satellite hemodialysis unit (Sponsored by 3SBIO, chaired by Chiu-Ching Huang, Taichung. Room 5A)

Lunch symposium 2: Towards a new era of peritoneal dialysis therapy (Sponsored by DCPC, Chaired by Tao Wang, Beijing. Room 5B)

12:00-12:50 Challenges and opportunities in peritoneal dialysis therapy (Tao Wang, Beijing)

12:50-13:20 Patient empowerment in peritoneal dialysis therapy (Chun-yan Su, Beijing)

13:20-13:30 Vision of DCPC (DCPC, Beijing)

 

13:30-14:00 Break

 

14:00-15:30

Symposium 1: Health economics and policy in dialysis (Chaired by John Agar, Australia and Jian-rong Zhang, Beijing. Room 5A)

14:00-14:30 Bundling system and the US dialysis changes (Andre A. Kaplan, USA)

14:30-15:00 HHD in Australia: the health economical impact (John Agar, Australia)

15:00-15:30 PD first policy: what have we learnt from Thailand (Piyatida Chuengsaman, Thailand)

 

Symposium 2: Cardiovascular diseases in dialysis therapy (Chaired by Bengt Lindholm, Sweden and Jian Liu, Xinjiang. Room 5B)

14:00-14:30 Intestine-renal link (Robert Zietse, Netherlands)

14:30-15:00 Volume control in dialysis patients: the tricks (Wen Tang, Beijing)

15:00-15:30 Emerging therapies for CVD in dialysis patients (Bengt Lindholm, Sweden)

 

Free communication 1: Blood purification in critical ill patients (Chaired by Tony Qureshi, Sweden and Qiang Jia, Beijing. Room 201A)

14:00-14:15 “U-shaped” association between timing of renal replacement therapy initiation and in-hospital mortality in acute kidney injury (Chih-Chung Shiao, Yilan)

14:15-14:30 The Hemodynamic effects during SLED versus CVVH for intracranial hemorrhage patients in a cross over study (Vin-Cent Wu, Taipei)

14:30-14:45 The effect of continuous veno-venous hemodiafiltration on monocyte function in Canine Model for multiple organ dysfunction syndrome (Ji-hong Chen, Urumqi)

14:45-15:00 Acute-on-chronic renal failure predicted long-term adverse out-come after major operation (Vin-Cent Wu, Taipei)

15:00-15:15 Scoring Short-term Mortality on Liver Failure Patients with Molecular Adsorbent Recirculating System Dialysis (Kuo-Chang Juan, Taipei)

 

Free communication 2: CVD in dialysis patients (Chaired by Jin-bor Chen, Kaohsiung and Song Wang, Beijing. Room 201B)

14:00-14:15 Pregnancy associated plasma protein A (PAPP-A) predicts mortality in long-term hemodialysis patients (Vladimir Tesar, Czech Republic)

14:15-14:30 Is epigenetic DNA hyper-methylation linked to chronic inflammation in Japanese dialysis patients? (Sawako Kato, Japan)

14:30-14:45 Outcomes of intensive intervention on fluid overload in chronic hemodialysis patients: a cross-sectional, case-control study (Po-Jui Chi, Kaohsiung)

14:45-15:00 Reverse epidemiology for blood pressure in incident hemodialysis patients: Reversal with the dry weight method (Charles Chazot, France)

15:00-15:15 Association between blood pressure and heart rate variability in normal volume status of continuous ambulatory peritoneal dialysis (Juan Pei, Beijing)

15:15-15:30 Longitudinal changes of diastolic dysfunction and predictors in patients on hemodialysis: A Tissue Doppler imaging study (Hiroshi Kimura, Japan)

 

15:30-16:00 Break, poster and exhibition

 

16:00-17:30

Symposium 3: Healthcare delivery model (Chaired by George Wu, Canada and De-tian Li, Shenyang. Room 5A)

16:00-16:30 Satellite self-care HD in Canada (George Wu, Canada)

16:30-17:00 What should be the role of medical center in dialysis therapy? (Shou-Shan Chiang, Taipei)

17:00-17:30 Dialysis chain and its management (Chao Sun, USA)

 

Symposium 4: New emerging technologies (Chaired by Andrew Davenport, UK and Xin-ling Liang, Guangzhou. Room 5B)

16:00-16:30 Wearable kidney (Andrew Davenport, UK)

16:30-17:00 Hemodiafiltration: the new era (Peter.J. Blankestijn, Netherlands)

17:00-17:30 The combination therapy (PD+HD) (Hideki Kawanishi, Japan)

 

Free communication 3: Healthcare delivery (Chaired by Piyatida Chuengsaman, Thailand and Maria Chan, Australia. Room 201A)

16:00-16:15 Big Challenges in Dialysis after the Great East Japan Earthquake (Yoshinori Tsuchiya, Japan)

16:15-16:30 Barriers for appropriate exercise in PD patients (Jun-yi Chen, Beijing)

16:30-16:45 Where do Home Hemodialysis Patients Go? Ten-years of experience (Shu-hong Bi, Beijing)

16:45-17:00 Pre-Dialysis Health Care in the Czech Republic – PREPARE Study (Ivan Rychlik, Czech Republic)

17:00-17:15 The Change of the Score from Home Visit Scorecard can predict Peritoneal Dialysis Outcome (Piyatida Chuengsaman, Thailand)

17:15-17:30 Malnutrition and serum albumin levels, but not BMI at initiation of dialysis are independent predictors of mortality (Maria. Chan, Australia)

 

Free communication 4: Miscellaneous (Chaired by Gokulnath, India and Xu-sheng Liu, Guangzhou. Room 201B)

16:00-16:15 Culture positive peritonitis: Interim analysis from “Outcomes of Peritoneal Dialysis Peritonitis in India - Multicenter Study” (Gokulnath, India)

16:15-16:30 Increased carotid artery stiffness in hypothyroid patients across all stages of chronic kidney disease (CKD) (Xing-wei Zhe, Kunming)

16:30-16:45 Continuous glucose monitoring system in glucose profile assessment and insulin pumps in diabetic nephropathy patients with CAPD (Shuang-xin Liu, Guangzhou)

16:45-17:00 Uric acid—another culprit for hypertension in Peritoneal Dialysis patients (Ya-jun Luo, Beijing)

17:00-17:15 The effect of saline concentration on exit-site infection control in PD patients (Zi-juan Zhou, Beijing)

17:15-17:30 Modeling of glucose-insulin system in patients on hemodialysis (Jacek Waniewski, Poland)

 

17:30-20:00 President dinner

 

September 11

 

08:30-09:00 Keynote lectures (Chaired by CHMDF, Beijing, Hall 2)

08:30-08:45 Chronic diseases: challenges and initiatives (CHMDF, Beijing)

08:45-09:00 Self-management in chronic disease (CNMA, Beijing)

09:00-09:40 Keynote lecture (Chaired by Robert Zietse, Netherlands and Mei Wang, Beijing. Hall 2)

The early history of dialysis and what we have learned that could be helpful in developing countries (Christopher R. Blagg, USA)

 

09:40-10:00 Break, poster and exhibition

 

10:00-12:00

Symposium 5: Facing the challenges of chronic diseases (Paul Tam, Canada and Tao Wang, Beijing. Hall 2)

UK experiences (Davenport Andrew)

US experiences (Andre Kaplan)

Swedish experiences (Bengt Lindholm)

Japanese experience (Takefumi Mori)

Taiwan experience (Jin-bor Chen)

Australia experience (David Johnson)

Mainland China experience （Wen-Hua Zhao）

Canadian experience: The Provincial renal care delivery for Ontario (Bharat Nathoo)

 

Symposium 6: Peritoneal dialysis (Chaired by Qiang Yao, Shanghai and Jie Dong, Beijing. Room 201)

10:00-10:30 Early vs. late start of dialysis: what does the trial tell us? (David Johnson, Australia)

10:30-11:00 Key strategies to prevent the dropout of PD patients (Jin-bor Chen, Kaohsiung)

11:00-11:30 Improving the quality of care in peritoneal dialysis (Adrian Liew, Singapore)

11:30-12:00 Best demonstrated practice in PD in Asia Pacific (Qiang Yao, Shanghai)

 

12:00-13:30 Lunch symposium

Lunch symposium 3: Hemodialysis program management (Sponsored by SUNCARE; Chaired by Jin-bor Chen, Kaohsiung and Ling Zhang, Beijing. Room 5A)

12:00-12:30 The successful experience of hemodialysis clinics in community in Taiwan (Ta Chuan Ceng, Kaohsiung)

12:30-13:00 The CQI program for HD center (Tun-ling Chen, Kaohsiung)

13:00-13:30 Hemodialysis program management (Jun-wei Yang, Nanjing)

 

Lunch symposium 4: Dry weight estimation in dialysis patients (Sponsored by Fresenius; Chaired by Kimura Tomoyoshi, Japan and Li Zuo, Beijing. Room 5B)

12:00-12:30 An overview of dry weight estimation in dialysis patients (Masahide Furusho, Japan)

12:30-13:00 The use of BCM in HD patients (Hui-hua Pang, Shanghai)

13:00-13:30 The use of BCM in PD patients (Wen Tang, Beijing)

 

13:30-14:00 Break

 

14:00-15:30

Symposium 7: Forum on chronic disease management (Chaired by Ao Wang, Beijing. Room 5A)

14:00-14:30 Traditional Chinese Medicine and chronic disease management (Xu-sheng Liu, Guangzhou)

14:30-15:00 Introducing the chronic disease management program in Tangshan (Tangshan City Healthcare Bureau)

15:00-15:30 Nutritional management in chronic disease (Xin-hong Lu, Beijing)

 

Symposium 8: Hemodialysis (Chaired by Chris Chan, Canada and Ai-hua Zhang, Beijing. Room 5B)

14:00-14:30 Nocturnal HD (Chris Chan, Canada)

14:30-15:00 Empower HD patients: what can we do (Ching-chu Alice Liang, Taipei)

15:00-15:30 Central dialysate delivery system: the Japanese experience (Hideki Kawanishi, Japan)

 

15:30-16:00 Break

 

16:00-17:30

Symposium 9: Forum on chronic disease management (Chaired by Takefumi Mori, Japan and Yu-bo Lv, Guangzhou. Room 5A)

16:00-16:30 Chronic disease management: theories and practice (Tao Wang, Beijing)

16:30-17:00 Hub and Spoke model of renal care delivery (Paul Tam, Canada)

17:00-17:30 Multidisciplinary care for pre-dialysis patient (Charmaine Lok, Canada)

 

Symposium 10: Emerging problems in dialysis in developing countries (Chaired by Tun-ling Chen, Taiwan and Li Zuo, Beijing. Room 5B)

16:00-16:30 Management: one fits to all or triage the patients, what is the ideal system (Chun-yan Su, Beijing)

16:30-17:00 Dialysis modality selection: why we are confused? (Li Zuo, Beijing)

17:00-17:30 Nutrition in dialysis patients (Meng-chuang Huang, Taipei)

 

17:30 Meeting adjourned

 

 

Note:

Slide preview room is located at the VIP room A on the second floor of the convention center. This room will be open 1:30-5:30pm on September 9 and 8am-5:30pm on September 10-11.

 

 

第二十九届国际血液净化学会年会暨首届慢性病管理论坛日程安排

（2011年9月9-11日）

 

ISBP 2011会前会(百特公司支持)

 

时间：2011年9月9日

 

地点：北京大学第三医院教学科研楼125会议室。由于会场位置有限，本次会前会需要提前免费申请。请希望参会的人员与会务组（isbp2011@yahoo.com.cn）联系相关事宜。

 

议程：

08:30-12:00 第一部分：创建高质量的腹膜透析中心

08:30-08:55 成功腹透中心的要素（汪涛，北京）

08:55-09:20 如何管理腹透中心（Hiroshi Kimura，日本）

09:20-09:45 日本大地震后腹透的现状（Yoshinori Tsuchiya，日本）

09:45-10:10 腹透中心的发展（Luo Xue Chun，新加坡）

 

10:10-10:30 茶歇

 

10:30-11:00 泰国首选腹透的经验（Piyatida Chuengsaman，泰国）

11:00-11:30 台湾腹透发展的经验（Jinbor Chen，高雄）

11:30-12:00 中国大陆腹透的发展概况（姚强，上海）

 

12:00-13:00 午餐

 

13:00-14:30 第二部分：如何在CKD和透析病人中做高质量的科研项目

13:00-13:15 Karolinska Institute 科研进展概述（Bengt Lindholm，瑞典）

13:15-13:30 终末期透析病人的免疫研究（Sawako Kato，日本）

13:30-13:45 白蛋白是营养和死亡的预测因子（Tony Qureshi，瑞典）

13:45-14:00 CKD病人的心血管功能研究（Shirley Hayashi，巴西）

14:00-14:15 CKD病人营养的研究（Maria Chan，澳大利亚）

 

14:15-14:30 茶歇

 

14:30-17:30 第三部分：透析动力学知识的临床应用

14:30-15:00 腹膜溶质和水分转运简介（Bengt Lindholm，瑞典）

15:00-15:30 中国腹膜转运相关研究概述（姚强，上海）

15:30-16:00 关于液体转运我们要了解什么？（Jacek Waniewski，瑞典）

16:00-16:30 如何在临床应用透析动力学知识？（汪涛，北京）

16:30-17:30 血透和腹透病人的动力学研究（者星伟、余洪磊，中国）

ISBP 2011正式会议

 

时间：2011年9月10-11日

 

地点：北京国际会议中心

大会注册台开放时间：9月9 号14:00pm-21:00pm，9月10号8:00am -5:30pm，9月11号8:00am-11:30am

 

议程：

 

9月10日

 

08:00-08:40 大会开幕式（主持人：Tadao Akizawa，日本；郑法雷教授，北京。第二会议室，配同声翻译）

1. 08:00-08:10 ISBP主席致欢迎辞（Tadao Akizawa，日本）

2. 08:10-08:20中国卫生部官员致欢迎辞

3. 08:20-08:30 中国健康促进基金会致欢迎辞（白书忠）

4. 08:30-08:40 组委会致辞及汇报会议筹备情况（汪涛）

 

08:40-9:30 ISBP大会颁奖（主持人：Tadao Akizawa，日本；Ingrid Ledebo，瑞典。第二会议室，配同声翻译）

1. 08:40-08:50 介绍ISBP大会奖及获奖人（Ingrid Ledebo，瑞典）

2. 08:50-09:30获奖人报告：台湾透析的发展及慢性肾脏病的预防中的经验和教训（Chiu-Ching Huang，台中）

 

9:30-10:15 主旨演讲（主持人：Andrew Davenport，英国；左力教授，北京。第二会议室，配同声翻译）

胃肠道相关的毒素：对慢性病及透析治疗的意义（Toshimitsu Niwa，日本）

 10:15-10:25 颁发最佳论文摘要奖(主持人：Andrew Davenport，英国；左力教授，北京。第二会议室)

将由国际腹膜透析学会Dr. Andre A. Kaplan颁发六名最佳摘要奖

 

10:25-10:45 茶歇、会展

 

10:45-12:00 辩论：到底哪种透析治疗是主要的方式？

（主持人：Andre A. Kaplan，美国；汪涛教授，北京。第二会议室，配同声翻译）

10:45-11:10 中心血透应该是尿毒症病人的主要治疗方式（梁馨苓，广州）

11:10-11:35 家庭血透应该是尿毒症病人的主要治疗方式（John Agar，澳大利亚）

11:35-12:00 腹膜透析应该是尿毒症病人的主要治疗方式（Wai-kei Lo，香港）

 

12:00-13:30 午餐卫星会

午餐卫星会1：基层透析中心连锁经营及质量管理体系的建立（三生公司）（主持人：Chiu-Ching Huang ，台中，5A）

午餐卫星会2：迈向腹透治疗的新时代（双鹤药业）（主持人：汪涛教授，北京，5B）

12:00-12:40 腹膜透析治疗的挑战和应对(汪涛教授，北京)

12:40-13:10 腹膜透析治疗中的病人管理(苏春燕，北京)

13:10-13:30 铸造双鹤品牌，畅想腹透明天(双鹤药业，北京)

 

13:30-14:00 休息

 

14:00-15:30

ISBP研讨会1：透析治疗的政策和卫生经济学思考

（主持人：John Agar，澳大利亚；张建荣教授，北京。5A）

14:00-14:30 打包付费制度和美国透析的变迁（Andre A. Kaplan，美国）

14:30-15:00 澳大利亚家庭血透项目对透析经济的影响（John Agar，澳大利亚）

15:00-15:30 泰国首选腹膜透析治疗的政策及结果（Piyatida Chuengsaman，泰国）

 

ISBP研讨会2：透析治疗的心血管合并症

（主持人：Bengt Lindholm，瑞典；刘健教授，新疆。5B）

14:00-14:30 胃肠道与肾脏的关系（Robert Zietse，荷兰）

14:30-15:00 透析病人的容量控制的技巧（唐雯，北京）

15:00-15:30 透析病人心血管合并症防控的新进展（Bengt Lindholm，瑞典）

 

口头宣读1：危重病人的血液净化治疗（主持人：Tony Qureshi，瑞典；贾强教授，北京。201A）

14:00-14:15 “U-shaped” association between timing of renal replacement therapy initiation and in-hospital mortality in acute kidney injury (Chih-Chung Shiao, Yilan)

14:15-14:30 The Hemodynamic effects during SLED versus CVVH for intracranial hemorrhage patients in a cross over study (Vin-Cent Wu, Taipei)

14:30-14:45 The effect of continuous veno-venous haemodiafiltration on monocyte function in Canine Model for multiple organ dysfunction syndrome (Ji-hong Chen, Urumqi)

14:45-15:00 Acute-on-chronicrenal failure predicted long-term adverse out-come after major operation (Vin-Cent Wu, Taipei)

15:00-15:15 Scoring Short-term Mortality on Liver Failure Patients with Molecular Adsorbent Recirculating System Dialysis (Kuo-Chang Juan, Taipei)

 

口头宣读2：透析病人的心血管合并症（主持人：Jin-bor Chen，高雄；王松教授，北京。201B）

        14:00-14:15 Pregnancy associated plasma protein A (PAPP-A) predicts mortality in long-term hemodialysis patients (Vladimir Tesar, Czech Republic)

14:15-14:30 Is epigenetic DNA hyper-methylation linked to chronic inflammation in Japanese dialysis patients? (Sawako Kato, Japan)

14:30-14:45 Outcomes of intensive intervention on fluid overload in chronic hemodialysis patients: a cross-sectional, case-control study (Po-Jui Chi, Kaohsiung)

14:45-15:00 Reverse epidemiology for blood pressure in incident hemodialysis patients: Reversal with the dry weight method (Charles Chazot, France)

15:00-15:15 Association between blood pressure and heart rate variability in normal volume status of continuous ambulatory peritoneal dialysis (Juan Pei, Beijing)

15:15-15:30 Longitudinal changes of diastolic dysfunction and predictors in patients on hemodialysis: A Tissue Doppler imaging study (Hiroshi Kimura, Japan)

 

15:30-16:00茶歇、会展

 

16:00-17:30

ISBP研讨会3：透析治疗提供方式

（主持人：George Wu，加拿大；李德天教授，沈阳。5A）

16:00-16:30 社区自助式透析：发展历程及经验总结（George Wu，加拿大）

16:30-17:00 三级甲等医院在血液透析治疗中应该怎样起作用（Shou-Shan Chiang ，台北）

17:00-17:30 连锁血液透析中心的管理（Chao Sun，美国）

 

ISBP研讨会4：透析新技术

（主持人：Andrew Davenport，英国；梁馨苓教授，广州。5B）

16:00-16:30 随身携带的人工肾脏（Andrew Davenport，英国）

16:30-17:00 血液透析滤过技术：透析的新时代（Peter.J. Blankestijn，荷兰）

17:00-17:30 杂合透析技术的发展：日本的经验（Hideki Kawanishi，日本）

 

口头宣读3：医疗照护模式（主持人：Piyatida Chuengsaman，泰国；Maria Chan，澳大利亚。201A）

16:00-16:15 Big Challenges in Dialysis after the Great East Japan Earthquake (Yoshinori Tsuchiya, Japan)

16:15-16:30 Barriers for appropriate exercise in PD patients (Jun-yi Chen, Beijing)

16:30-16:45 Where do Home HemodialysisPatients Go? Ten-years of experience (Shu-hong Bi, Beijing)

        16:45-17:00 Pre-Dialysis Health Care in the Czech Republic – PREPARE Study (Ivan Rychlik, Czech Republic)

17:00-17:15 The Change of the Score from Home Visit Scorecard can predict Peritoneal Dialysis Outcome (Piyatida Chuengsaman, Thailand)

17:15-17:30 Malnutritionand serum albumin levels, but not BMI at initiation of dialysis are independent predictors of mortality (Maria. Chan, Australia)

 

口头宣读4：其他（主持人：Gokulnath，印度；刘旭生教授，广州。201B）

16:00-16:15 Culture positive peritonitis: Interim analysis from “Outcomes of Peritoneal DialysisPeritonitis in India - Multicenter Study” (Gokulnath, India)

16:15-16:30 Increased carotid artery stiffness in hypothyroid patients across all stages of chronic kidney disease (CKD) (Xing-wei Zhe, Kunming)

16:30-16:45 Continuous glucose monitoring system in glucose profile assessment and insulin pumps in diabetic nephropathy patients with CAPD (Shuang-xin Liu, Guangzhou)

16:45-17:00 Uric acid—another culprit for hypertension in Peritoneal Dialysis patients (Ya-jun Luo, Beijing)

17:00-17:15 The effect of saline concentration on exit-site infection control in PD patients (Zi-juan Zhou, Beijing)

17:15-17:30 Modeling of glucose-insulin system in patients on hemodialysis (Jacek Waniewski, Poland)

 

17:30-20:00 讲者晚宴

 

9月11日

 

08:30-09:00主旨演讲（主持人：中国医药卫生事业发展基金会领导，北京。第二会议室，配同声翻译）

08:30-08:45 慢性病的挑战与应对（中国医药卫生事业发展基金会领导）

08:45-09:00 慢性病的自我保健与管理（中国非处方药物协会领导）

09:00-09:40主旨演讲：（主持人：Robert Zietse，荷兰；王梅教授，北京，第二会议室，配同声翻译）

透析的历史：我们有哪些经验和教训？（Christopher R. Blagg，美国）

 

09:40-10:00茶歇、会展

 

10:00-12:00

慢性病管理研讨会1：慢性病管理及健康管理各地经验大讨论（Paul Tam，加拿大；汪涛教授，北京。第二会议室，配同声翻译）

英国的经验（Davenport Andrew）

美国的经验（Andre Kaplan）

瑞典的经验（Bengt Lindholm）

日本的经验（Takefumi Mori）

台湾的经验（Jin-bor Chen）

澳大利亚的经验（David Johnson）

中国大陆的经验(赵文华，中国疾控中心研究员)

加拿大的经验（Bharat Nathoo）

 

ISBP研讨会5：腹膜透析（主持人：姚强，上海；董捷教授，北京。201）

10:00-10:30 何时开始腹膜透析？（David Johnson，澳大利亚）

10:30-11:00 降低腹膜透析退出率的关键策略（Jin-bor Chen，高雄）

11:00-11:30 提高腹膜透析的治疗质量（Adrian Liew，新加坡）

11:30-12:00 亚太地区腹膜透析快速发展的新经验（姚强，上海）

 

12:00-13:30 午餐卫星会

午餐卫星会3：血液透析中心管理（杏康）（主持人：陈靖博，高雄；张凌教授，北京。5A）

12:00-12:30 血液透析诊所社区化在台湾成功的经验（曾达权，高雄）

12:30-13:00 BDP医疗品质分析（陈敦领，高雄）

13:00-13:30 建立血液净化中心的理念和管理模式（杨俊伟，南京）

 

午餐卫星会4：生物电阻抗在透析病人中的应用（费森尤斯公司）（主持人：Kimura Tomoyoshi，日本；左力教授，北京。5B）

12:00-12:30 透析病人干体重及其评估（Masahide Furusho，日本）

12:30-13:00 生物电阻抗仪在血透治疗中的应用（庞慧华，上海）

13:00-13:30 生物电阻抗仪在腹透治疗中的应用（唐雯，北京）

 

13:30-14:00 休息

 

14:00-15:30

慢性病管理研讨会2：慢性病管理体系建设1（主持人：中国非处方药物协会汪鳌，5A）

14:00-14:30中医与慢性病管理（刘旭生，广州）

14:30-15:00 做好以“三高”人群为重点的慢性病管理工作（唐山卫生系统领导）

15:00-15:30慢性病的饮食和营养管理（鲁新红，北京）

 

ISBP研讨会6：血液透析（主持人：Chris Chan，加拿大；张爱华教授，北京。5B）

14:00-14:30 隔天的夜间长时间透析的发展和经验（Christopher Chan，加拿大）

14:30-15:00 透析治疗中如何授权病人（Ching-chu Alice Liang，台北）

15:00-15:30 血透中心中央供液系统：日本的经验（Hideki Kawanishi，日本）

 

15:30-16:00 休息

 

16:00-17:30

慢性病管理研讨会3：慢性病管理的体系建设2（主持人：Takefumi Mori 日本；吕玉波教授，广州。5A）

16:00-16:30 慢性病管理的理论与实践（汪涛，北京）

16:30-17:00 加拿大的肾脏照护模式介绍（Paul Tam，加拿大）

17:00-17:30 透前病人的多专业照护（Charmaine Lok，加拿大）

 

ISBP研讨会7：发展中国家透析的新问题

（主持人：Tun-ling Chen，台湾；左力教授，北京。5B）

16:00-16:30 透析治疗的管理：统一规范还是个性化？（苏春燕，北京）

16:30-17:00 为什么医护人员对透析治疗方式的选择很困惑？（左力，北京）

17:00-17:30 透析病人的营养治疗（Meng-chuang Huang，台北）

 

17:30 会议结束